Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Bassan R, Chiaretti S, Della Starza I, Spinelli O, Santoro A, Paoloni F, Messina M, Elia L, De Propris MS, Scattolin AM, Audisio E, Marbello L, Borlenghi E, Zappasodi P, Mauro E, Martinelli G, Mattei D, Fracchiolla N, Bocchia M, De Fabritiis P, Bonifacio M, Candoni A, Cassibba V, Di Bartolomeo P, Latte G, Trappolini S, Guarini A, Vitale A, Fazi P, Piciocchi A, Rambaldi A, Foà R. Bassan R, et al. Among authors: mauro e. Blood Adv. 2023 Aug 22;7(16):4448-4461. doi: 10.1182/bloodadvances.2022009596. Blood Adv. 2023. PMID: 37276451 Free PMC article.
A case of high-risk AML in a patient with advanced systemic mastocytosis.
Fazio M, Vetro C, Markovic U, Duminuco A, Parisi M, Maugeri C, Mauro E, Parrinello NL, Stagno F, Villari L, Triolo AM, Stella S, Palumbo GA, Di Raimondo F, Romano A, Zanotti R. Fazio M, et al. Among authors: mauro e. Clin Case Rep. 2023 Jul 17;11(7):e7134. doi: 10.1002/ccr3.7134. eCollection 2023 Jul. Clin Case Rep. 2023. PMID: 37469366 Free PMC article.
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data.
Gozzo L, Nardo A, Brancati S, Judica A, Duminuco A, Maugeri C, Parisi M, Longo L, Vitale DC, Ruscica R, Romano GL, Mauro E, Fiumara PF, Palumbo GAM, Di Raimondo F, Vetro C, Drago F. Gozzo L, et al. Among authors: mauro e. Healthcare (Basel). 2023 May 18;11(10):1479. doi: 10.3390/healthcare11101479. Healthcare (Basel). 2023. PMID: 37239765 Free PMC article.
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.
Leotta S, Markovic U, Duminuco A, Mulè A, Porretto F, Federico V, Gentile M, Pastore D, Nigro LL, Selleri C, Serio B, Calafiore V, Patti C, Mauro E, Vetro C, Maugeri C, Parisi M, Fiumara P, Parrinello L, Marino S, Scuderi G, Garibaldi B, Musso M, Renzo ND, Vigna E, Martino EA, Raimondo FD, Milone G. Leotta S, et al. Among authors: mauro e. Ann Hematol. 2024 Apr 13. doi: 10.1007/s00277-024-05725-9. Online ahead of print. Ann Hematol. 2024. PMID: 38609726
Carbapenem-Resistant Enterobacteriaceae in Urinary Tract Infections: From Biological Insights to Emerging Therapeutic Alternatives.
Bologna E, Licari LC, Manfredi C, Ditonno F, Cirillo L, Fusco GM, Abate M, Passaro F, Di Mauro E, Crocetto F, Pandolfo SD, Aveta A, Cilio S, Di Filippo I, Barone B, Franco A, Arcaniolo D, La Rocca R, Pinchera B, Napolitano L. Bologna E, et al. Among authors: di mauro e. Medicina (Kaunas). 2024 Jan 26;60(2):214. doi: 10.3390/medicina60020214. Medicina (Kaunas). 2024. PMID: 38399502 Free PMC article. Review.
Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list.
Perdiguero GG, Spina JC, Martínez J, Savluk L, Saidman J, Bonifacio M, Bakken S, Padilla M, Gallego-Clemente E, Moreno-González V, De Santibañes M, Marciano S, De Santibañes E, Gadano A, Pekolj J, Abraldes JG, Mauro E. Perdiguero GG, et al. Among authors: mauro e. JHEP Rep. 2023 Dec 19;6(3):100985. doi: 10.1016/j.jhepr.2023.100985. eCollection 2024 Mar. JHEP Rep. 2023. PMID: 38384670 Free PMC article.
A mobile health application for prostate cancer antigen dosage: is it time to say goodbye to classic screening methods?
Di Bello F, di Mauro E, Fusco GM, Falcone A, Pezone G, Ruvolo CC, Califano G, Fraia A, Passaro F, Pepillo F, Ranieri A, Alvino P, Mastrangelo F, Turco C, Cirillo L, Franzese CA, La Rocca R, Creta M, Longo N, Napolitano L. Di Bello F, et al. Among authors: di mauro e. Eur J Cancer Prev. 2024 Mar 1;33(2):87-94. doi: 10.1097/CEJ.0000000000000845. Epub 2023 Nov 29. Eur J Cancer Prev. 2024. PMID: 38051582
327 results